Literature DB >> 4826614

Osteoporosis in ovarian dysgenesis.

D M Brown, J Jowsey, D S Bradford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4826614     DOI: 10.1016/s0022-3476(74)80755-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

Review 1.  Sex hormone replacement in Turner syndrome.

Authors:  Christian Trolle; Britta Hjerrild; Line Cleemann; Kristian H Mortensen; Claus H Gravholt
Journal:  Endocrine       Date:  2011-12-07       Impact factor: 3.633

2.  Serum bone Gla protein in streak gonad syndrome.

Authors:  J Zséli; P Bösze; P Lakatos; P Vargha; G Tarján; E Kollin; C Horváth; J László; I Holló
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

3.  Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover.

Authors:  R W Naeraa; K Brixen; R M Hansen; C Hasling; L Mosekilde; J H Andresen; P Charles; J Nielsen
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

4.  Skeletal demineralization in Turner's syndrome.

Authors:  R M Shore; R W Chesney; R B Mazess; P G Rose; G J Bargman
Journal:  Calcif Tissue Int       Date:  1982       Impact factor: 4.333

5.  Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients.

Authors:  R W Holl; D Kunze; H Etzrodt; W Teller; E Heinze
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

6.  Bone demineralisation in patients with Turner's syndrome.

Authors:  M A Smith; J Wilson; W H Price
Journal:  J Med Genet       Date:  1982-04       Impact factor: 6.318

Review 7.  Hormones and bone health in postmenopausal women.

Authors:  Robert Lindsay
Journal:  Endocrine       Date:  2004-08       Impact factor: 3.633

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.